{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T15:10:28Z","timestamp":1771168228652,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1038\/s10038-022-01110-4","type":"journal-article","created":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T06:02:54Z","timestamp":1673416974000},"page":"359-361","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Japanese case of familial malignant melanoma with germline CDK4 variant incidentally diagnosed by cancer genome profiling"],"prefix":"10.1038","volume":"68","author":[{"given":"Yoshimi","family":"Kiyozumi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shusuke","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Kiyohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Tsushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiro","family":"Kado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiichiro","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satomi","family":"Higashigawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rina","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kana","family":"Kunitomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi","family":"Fukuzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7050-2351","authenticated-orcid":false,"given":"Hiroyuki","family":"Matsubayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,11]]},"reference":[{"key":"1110_CR1","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1001\/jama.1986.03380140085027","volume":"256","author":"AW Kopf","year":"1986","unstructured":"Kopf AW, Hellman LJ, Rogers GS, Gross DF, Rigel DS, Friedman RJ, et al. Familial malignant melanoma. JAMA. 1986;256:1915\u20139.","journal-title":"JAMA"},{"key":"1110_CR2","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1038\/sj.onc.1206445","volume":"22","author":"NK Hayward","year":"2003","unstructured":"Hayward NK. Genetics of melanoma predisposition. Oncogene. 2003;22:3053\u201362.","journal-title":"Oncogene"},{"key":"1110_CR3","first-page":"2754","volume":"53","author":"T Takenouchi","year":"1995","unstructured":"Takenouchi T, Ito M. Familial malignant melanoma. Nihon Rinsho. 1995;53:2754\u20138.","journal-title":"Nihon Rinsho"},{"key":"1110_CR4","doi-asserted-by":"publisher","unstructured":"Ebi H, Bando H. Precision oncology and the universal health coverage system in Japan. JCO Precis Oncol. 2019;3. https:\/\/doi.org\/10.1200\/PO.19.00291.","DOI":"10.1200\/PO.19.00291"},{"key":"1110_CR5","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/jjco\/hyac046","volume":"52","author":"S Higashigawa","year":"2022","unstructured":"Higashigawa S, Matsubayashi H, Kiyozumi Y, Kado N, Nishimura S, Oishi T, et al. Present status of germline findings in precision medicine for Japanese cancer patients: issues in the current system. Jpn J Clin Oncol. 2022;52:599\u2013608.","journal-title":"Jpn J Clin Oncol"},{"key":"1110_CR6","unstructured":"Eckerle Mize D, Bishop M, Resse E, Sluzevich J. Familial Atypical Multiple Mole Melanoma Syndrome. In: Riegert-Johnson DL, Boardman LA, Hefferon T, Roberts M, eds. Cancer Syndromes. Bethesda (MD), 2009."},{"key":"1110_CR7","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.jaad.2010.06.067","volume":"65","author":"JI van der Rhee","year":"2011","unstructured":"van der Rhee JI, de Snoo FA, Vasen HFA, Mooi WJ, Putter H, Gruis NA, et al. Effectiveness and causes for failure of surveillance of CDKN2A-mutated melanoma families. J Am Acad Dermatol. 2011;65:289\u2013296.","journal-title":"J Am Acad Dermatol"},{"key":"1110_CR8","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1111\/cup.13689","volume":"47","author":"A Toussi","year":"2020","unstructured":"Toussi A, Mans N, Welborn J, Kiuru M. Germline mutations predisposing to melanoma. J Cutan Pathol. 2020;47:606\u2013616.","journal-title":"J Cutan Pathol"},{"key":"1110_CR9","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1001\/archdermatol.2010.19","volume":"146","author":"HW Rogers","year":"2010","unstructured":"Rogers HW, Weinstock MA, Harris AR, Hinckley MR, Feldman SR, Fleischer AB, et al. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol. 2010;146:283\u20137.","journal-title":"Arch Dermatol"},{"key":"1110_CR10","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/jjco\/hyr184","volume":"42","author":"T Matsuda","year":"2012","unstructured":"Matsuda T, Marugame T, Kamo K, Katanoda K, Ajiki W, Sobue T, et al. Cancer incidence and incidence rates in Japan in 2006: based on data from 15 population-based cancer registries in the monitoring of cancer incidence in Japan (MCIJ) project. Jpn J Clin Oncol. 2012;42:139\u201347.","journal-title":"Jpn J Clin Oncol"},{"key":"1110_CR11","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.soc.2008.08.003","volume":"18","author":"AA Santillan","year":"2009","unstructured":"Santillan AA, Cherpelis BS, Glass LF, Sondak VK. Management of familial melanoma and nonmelanoma skin cancer syndromes. Surg Oncol Clin N. Am. 2009;18:73\u201398. viii","journal-title":"Surg Oncol Clin N. Am"},{"key":"1110_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/00008390-200202000-00008","volume":"12","author":"AM Goldstein","year":"2002","unstructured":"Goldstein AM, Chidambaram A, Halpern A, Holly EA, Guerry IV D, Sagebiel R, et al. Rarity of CDK4 germline mutations in familial melanoma. Melanoma Res. 2002;12:51\u20135.","journal-title":"Melanoma Res"},{"key":"1110_CR13","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1136\/jmedgenet-2012-101455","volume":"50","author":"HE Puntervoll","year":"2013","unstructured":"Puntervoll HE, Yang XR, Vetti HH, Bachmann IM, Avril MF, Benfodda M, et al. Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants. J Med Genet. 2013;50:264\u201370.","journal-title":"J Med Genet"},{"key":"1110_CR14","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1128\/MCB.22.2.644-656.2002","volume":"22","author":"SG Rane","year":"2002","unstructured":"Rane SG, Cosenza SC, Mettus RV, Reddy EP. Germ line transmission of the Cdk4(R24C) mutation facilitates tumorigenesis and escape from cellular senescence. Mol Cell Biol. 2002;22:644\u201356.","journal-title":"Mol Cell Biol"},{"key":"1110_CR15","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/hmg\/7.2.209","volume":"7","author":"N Soufir","year":"1998","unstructured":"Soufir N, Avril MF, Chompret A, Demenais F, Bombled J, Spatz A, et al. Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group. Hum Mol Genet. 1998;7:209\u201316.","journal-title":"Hum Mol Genet"},{"key":"1110_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/gcc.20202","volume":"44","author":"A Molven","year":"2005","unstructured":"Molven A, Grimstvedt MB, Steine SJ, Harland M, Avril MF, Hayward NK, et al. A large Norwegian family with inherited malignant melanoma, multiple atypical nevi, and CDK4 mutation. Genes Chromosomes Cancer. 2005;44:10\u20138.","journal-title":"Genes Chromosomes Cancer"},{"key":"1110_CR17","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/CMR.0b013e3283608695","volume":"23","author":"R Veinalde","year":"2013","unstructured":"Veinalde R, Ozola A, Azarjana K, Molven A, Akslen LA, Doni\u0146a S, et al. Analysis of Latvian familial melanoma patients shows novel variants in the noncoding regions of CDKN2A and that the CDK4 mutation R24H is a founder mutation. Melanoma Res. 2013;23:221\u20136.","journal-title":"Melanoma Res"}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s10038-022-01110-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s10038-022-01110-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s10038-022-01110-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T23:02:47Z","timestamp":1682377367000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s10038-022-01110-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,11]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["1110"],"URL":"https:\/\/doi.org\/10.1038\/s10038-022-01110-4","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"value":"1434-5161","type":"print"},{"value":"1435-232X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,11]]},"assertion":[{"value":"7 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"A written informed consent for the publication was obtained from the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}